4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0001193125-26-019723
Options or other derivatives
- Chief Executive Officer acquired 1,165,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
MacBeath Gavin · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-20 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +1,165,000 | 1,165,000 | D |
Loading xslF345X05/ownership.xml…